Cargando…
The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes
OBJECTIVE: Increasing uptake of cancer screening is a priority for health systems internationally, however, some patients may not attend because they are undergoing active treatment for the cancer of interest or have other medical reasons that mean participation would be inappropriate. This study ai...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429165/ https://www.ncbi.nlm.nih.gov/pubmed/25753487 http://dx.doi.org/10.1177/0969141315572173 |
_version_ | 1782370992682696704 |
---|---|
author | Mead, L Porteous, L Tait, M Stoker, R Payne, S Calvert, C Maxwell, D Katikireddi, SV |
author_facet | Mead, L Porteous, L Tait, M Stoker, R Payne, S Calvert, C Maxwell, D Katikireddi, SV |
author_sort | Mead, L |
collection | PubMed |
description | OBJECTIVE: Increasing uptake of cancer screening is a priority for health systems internationally, however, some patients may not attend because they are undergoing active treatment for the cancer of interest or have other medical reasons that mean participation would be inappropriate. This study aims to quantify the proportion of non-participants who have a medical reason for not attending cancer screening. METHODS: Medical reasons for not participating in breast and bowel screening were defined a priori on the basis of a literature review and expert opinion. The notes of 700 patients at two GP practices in Scotland were reviewed, to ascertain the prevalence of medical reasons amongst non-participants. Simple proportions and confidence intervals were calculated. RESULTS: 17.4% of breast and 2.3% of bowel screening non-participants had a medical reason to not participate. The two most common reasons were previous breast cancer follow up (8.86%) and recent mammogram (6.57%). CONCLUSION: These patients may not benefit from screening while also being distressed by receiving an invitation. This issue also makes accurate monitoring and target-setting for improving uptake difficult. Further work is needed to estimate robustly the extent to which medical reasons account for screening non-participation in a larger population. |
format | Online Article Text |
id | pubmed-4429165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-44291652015-05-31 The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes Mead, L Porteous, L Tait, M Stoker, R Payne, S Calvert, C Maxwell, D Katikireddi, SV J Med Screen Short Communications OBJECTIVE: Increasing uptake of cancer screening is a priority for health systems internationally, however, some patients may not attend because they are undergoing active treatment for the cancer of interest or have other medical reasons that mean participation would be inappropriate. This study aims to quantify the proportion of non-participants who have a medical reason for not attending cancer screening. METHODS: Medical reasons for not participating in breast and bowel screening were defined a priori on the basis of a literature review and expert opinion. The notes of 700 patients at two GP practices in Scotland were reviewed, to ascertain the prevalence of medical reasons amongst non-participants. Simple proportions and confidence intervals were calculated. RESULTS: 17.4% of breast and 2.3% of bowel screening non-participants had a medical reason to not participate. The two most common reasons were previous breast cancer follow up (8.86%) and recent mammogram (6.57%). CONCLUSION: These patients may not benefit from screening while also being distressed by receiving an invitation. This issue also makes accurate monitoring and target-setting for improving uptake difficult. Further work is needed to estimate robustly the extent to which medical reasons account for screening non-participation in a larger population. SAGE Publications 2015-06 /pmc/articles/PMC4429165/ /pubmed/25753487 http://dx.doi.org/10.1177/0969141315572173 Text en © The Author(s) 2015 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(http://www.uk.sagepub.com/aboutus/openaccess.htm). |
spellingShingle | Short Communications Mead, L Porteous, L Tait, M Stoker, R Payne, S Calvert, C Maxwell, D Katikireddi, SV The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes |
title | The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes |
title_full | The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes |
title_fullStr | The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes |
title_full_unstemmed | The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes |
title_short | The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes |
title_sort | prevalence of medical reasons for non-participation in the scottish breast and bowel cancer screening programmes |
topic | Short Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429165/ https://www.ncbi.nlm.nih.gov/pubmed/25753487 http://dx.doi.org/10.1177/0969141315572173 |
work_keys_str_mv | AT meadl theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT porteousl theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT taitm theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT stokerr theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT paynes theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT calvertc theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT maxwelld theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT katikireddisv theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT meadl prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT porteousl prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT taitm prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT stokerr prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT paynes prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT calvertc prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT maxwelld prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes AT katikireddisv prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes |